OpenBilldrug price receipt

NADAC week of 2026-10-14

TOBRAMYCIN-DEXAMETH OPHTH SUSP

For 1 mL

Pharmacies pay

$4.01 – $4.57 filed

1 × $4.01206 to $4.56623 per ML (the 9 NDCs differ)

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$8.60 filed

1 × $8.59857 per ML, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

1.9× – 2.1× estimated

Medicare paid between 1.9× and 2.1× what pharmacies pay, depending on the NDC.

Part D averages every strength and form sold under “Tobramycin-Dexamethasone” / “Tobramycin/Dexamethasone” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$9.61 – $10.26 estimated

NADAC for the pack + 15% + $5.00 fee per fill

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

TOBRAMYCIN-DEXAMETH OPHTH SUSP is how the CMS NADAC file names this product. The FDA NDC Directory lists it as tobramycin and dexamethasone.

FDA gives its dosage form as suspension/ drops and its route as ophthalmic.

Its labelers, the companies named on the label, are Padagis US LLC, Bausch & Lomb Incorporated and Sandoz Inc.

FDA lists it under 2 Established Pharmacologic Classes: Aminoglycoside Antibacterial and Corticosteroid.

The NADAC file of 2026-10-14 prices it under 9 NDCs (National Drug Codes).

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $4.01 – $4.57 for 1 mL, depending on the NDC ($4.01206 to $4.56623 per ML), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 5, calculated based on package size; 6, the CMS Covered Outpatient Drug Product File S/I/N drug category was not applied when grouping drugs for the calculation.

The 3 labelers

LabelerNDCsPharmacies pay per unit
Bausch & Lomb Incorporated3$4.01206 to $4.56623 per ML filed
Padagis US LLC3$4.01206 to $4.56623 per ML filed
Sandoz Inc3$4.01206 to $4.56623 per ML filed
All 9 NDCs, with labeler and price
  • 00574-4031-05 · Padagis US LLC · $4.01206 per ML · eff. 2026-09-23 filed
  • 00574-4031-10 · Padagis US LLC · $4.1784 per ML · eff. 2026-09-23 filed
  • 00574-4031-25 · Padagis US LLC · $4.56623 per ML · eff. 2026-09-23 filed
  • 24208-0295-05 · Bausch & Lomb Incorporated · $4.01206 per ML · eff. 2026-09-23 filed
  • 24208-0295-10 · Bausch & Lomb Incorporated · $4.1784 per ML · eff. 2026-09-23 filed
  • 24208-0295-25 · Bausch & Lomb Incorporated · $4.56623 per ML · eff. 2026-09-23 filed
  • 61314-0647-05 · Sandoz Inc · $4.01206 per ML · eff. 2026-09-23 filed
  • 61314-0647-10 · Sandoz Inc · $4.1784 per ML · eff. 2026-09-23 filed
  • 61314-0647-25 · Sandoz Inc · $4.56623 per ML · eff. 2026-09-23 filed

Other strengths, forms and brands

1 other product in the NADAC file shares the FDA nonproprietary name tobramycin and dexamethasone with TOBRAMYCIN-DEXAMETH OPHTH SUSP.

ProductPharmacies pay per unitMedicare per unit
TOBRADEX EYE OINTMENT
brand · ointment
$89.7148 per GM filed
eff. 2026-09-23
$75.94132 per GM filed
Part D 2024 average
TOBRAMYCIN-DEXAMETH OPHTH SUSP this page
generic · suspension/ drops
$4.01206 to $4.56623 per ML filed
eff. 2026-09-23
$8.59857 per ML filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 9 NDCs’ NADAC prices is $4.1784 per ML filed.

Of the 15 other products in FDA’s Aminoglycoside Antibacterial class priced per ML, 7 have a higher middle NADAC price and 8 a lower one. The one in the middle is NEOMYCIN-POLYMYXIN-HC EAR SUSP, at $3.83312 per ML filed (eff. 2026-09-23).

Of the 106 other products in FDA’s Corticosteroid class priced per ML, 43 have a higher middle NADAC price and 63 a lower one. The one in the middle is FLUNISOLIDE 0.025% SPRAY, at $1.98777 per ML filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $8.60 for 1 mL, at an average of $8.59857 per ML in 2024 (2024-01-01 to 2024-12-31) for “Tobramycin-Dexamethasone” and “Tobramycin/Dexamethasone”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 518,468 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for TOBRAMYCIN-DEXAMETH OPHTH SUSP labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Tobramycin-Dexamethasone / Tobramycin/Dexamethasone: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's ML. Joined on generic name.
Why does this page start at 1 mL?
The FDA package descriptions of this product’s NDCs give different amounts (2.5 mL, 5 mL, 10 mL). So the card starts at 1 ML; change it to match your prescription.